1.74
+0.03(+1.75%)
Currency In USD
| Previous Close | 1.71 |
| Open | 1.71 |
| Day High | 1.75 |
| Day Low | 1.7 |
| 52-Week High | 9.37 |
| 52-Week Low | 1.47 |
| Volume | 132,417 |
| Average Volume | 634,774 |
| Market Cap | 70.9M |
| PE | -1.22 |
| EPS | -1.43 |
| Moving Average 50 Days | 1.95 |
| Moving Average 200 Days | 4.51 |
| Change | 0.03 |
If you invested $1000 in Pulmonx Corporation (LUNG) since IPO date, it would be worth $44.26 as of September 29, 2025 at a share price of $1.74. Whereas If you bought $1000 worth of Pulmonx Corporation (LUNG) shares 3 years ago, it would be worth $101.99 as of September 29, 2025 at a share price of $1.74.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pulmonx to Participate in September Investor Conferences
GlobeNewswire Inc.
Aug 26, 2025 8:05 PM GMT
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at the followin
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 29, 2025 8:05 PM GMT
REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Canacc
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025
GlobeNewswire Inc.
Jul 16, 2025 8:05 PM GMT
REDWOOD CITY, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for t